/ / /
Michael brings more than 10 years of experience in life sciences investing, company building, and transaction advisory. While at GPC, Michael has been integrally involved across a range of investments, including Corium, Naveris, and Auregen.
Prior to joining GPC, Michael worked in investment banking at MTS Health Partners. At MTS, Michael specialized in merger and acquisitions and financings across the biotechnology, pharmaceuticals, and healthcare services sectors.
Michael graduated from the Roy and Diana Vagelos Program at the University of Pennsylvania, where he earned both a BA in Biology and a BS in Economics with a concentration in Finance.